Project Grant R35GM154896

Award Date 8/15/24
Completion Date 7/31/29
Dollars Obligated $406K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) project grant, valued at $1,218,750.00 and awarded on August 1, 2024, supports research to characterize the regulatory networks and mechanisms of retrotransposable elements (REs) in mammalian development. The project aims to leverage this understanding to explore the therapeutic potential of "synthetic RE-reactivation" to re-engage beneficial properties in...
The National Institute of General Medical Sciences (NIGMS) awarded a $1,286,156 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The award, effective September 1, 2024 through August 31, 2029, will fund research to address core issues regarding cytokinesis, the process of cell division, and the septin cytoskeleton, which forms scaffolds that impact...
The National Institute of General Medical Sciences (NIGMS) awarded a $479,924 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The Pennsylvania State University, effective September 1, 2024 through August 31, 2029. The grant supports research to determine how RNA structure regulates gene expression co-transcriptionally in Escherichia coli and Bacillus subtilis. Key focus areas include investigating the roles of transcription elongation factors NusA and NusG in...
This $451,802 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports structural studies of the direct associations between cellular RNA polymerase and regulatory factors during the transcription cycle. The research, conducted by The Pennsylvania State University, aims to investigate the heterogeneity and dynamics of RNA polymerase transcription using cryo-electron microscopy, single-molecule,...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) in the amount of $316,968.00 provides funding to Emory University to conduct research on the regulation, inhibition, and quality control mechanisms of ribosomes. The five-year award, effective June 1, 2025 through May 31, 2030, focuses on three key themes: 1) understanding translation fidelity events including miscoding, quality control,...
This $328,000 federal Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports the development and application of an RNA editing platform called TRIBE-ID. The platform will be used to investigate dynamic RNA-protein interactions in cells, with the goal of advancing the understanding of RNA regulatory mechanisms and accelerating the development of RNA-targeted therapeutics....
This $1,675,000 project grant from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will fund research at Yale University to investigate the post-transcriptional control of gene expression by the mTORC1 signaling pathway. The research aims to answer key questions about how mRNA features define dependence on cap-dependent and cap-independent translation mechanisms, how regulation of cap-dependent translation triggers...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 Biomedical Research and Research Training program provides $678,000.00 in funding to Rockefeller University to study the molecular mechanisms governing the assembly of eukaryotic ribosomes. The long-term goal is to develop a detailed understanding of how the over 200 non-ribosomal factors coordinate the co-transcriptional and post-transcriptional stages of eukaryotic ribosome...
The National Institute of General Medical Sciences (NIGMS) awarded a $406,250 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to The Trustees of the University of Pennsylvania, with a performance period from June 1, 2025 to April 30, 2030. The grant supports two key research directions: 1) investigating the mechanisms of transcription factor functional divergence and its role in driving cellular and organismal complexity, and 2) identifying the genetic...
This $1,102,648 federal Project Grant award was provided by the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), to The Trustees of Columbia University in the City of New York. The award supports research to globally map protein-protein interactions and protein-RNA interactions for hundreds of RNA binding proteins (RBPs) at multiple time points during embryonic stem cell differentiation. The goal is to provide...

This federal Project Grant award from the National Institute of General Medical Sciences (CFDA 93.859 - Biomedical Research and Research Training) provides $406,250.00 to The Trustees of the University of Pennsylvania over a 5-year period from August 15, 2024 to July 31, 2029. The research focuses on mapping the post-transcriptional aspects of gene expression, with a specific emphasis on understanding alternative ribosome initiation and the role of RNA modifications and binding proteins in regulating RNA selection and spatial interactions. The goal is to characterize the global utilization of nonconventional translation initiation and its impact on cellular phenotypes during cancer progression. This multidisciplinary effort will connect unbiased ribosome sequencing with proteomic profiling to identify the complete oncogenic proteome and the features that impose RNA selection. The findings are expected to provide unprecedented insights into RNA regulation and genetic diversity through noncanonical translation, which could lead to innovative therapeutic approaches.

Generated 7/1/25, 3:35 AM